Highlights Jenburkt Pharmaceuticals Limited

Equities

JENBURPH6

INE354A01013

Market Closed - Bombay S.E. Other stock markets 11:00:57 02/07/2024 BST			5-day change	1st Jan Change
880.2 ^INR	-0.32%		-0.33%	+29.41%

05-28	Jenburkt Pharmaceuticals Limited Announces Board Retirements	CI
05-28	Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jenburkt Pharmaceuticals Limited Announces Dividend	05-28	CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-28	CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-06	CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-07	CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	08/08/23	CI
Jenburkt Pharmaceuticals Limited Approves Dividend for the Financial Year Ended 31 March, 2023	26/07/23	CI
Ex-dividend day for final dividend	18/07/23	FA
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23/05/23	CI
Jenburkt Pharmaceuticals Limited Approves Dividend	23/05/23	CI
Tranche Update on Jenburkt Pharmaceuticals Limited's Equity Buyback Plan announced on December 1, 2022.	24/03/23	CI
Jenburkt Pharmaceuticals Limited's Equity Buyback announced on December 1, 2022, has closed with repurchase of 176,078 shares, representing 3.84% for INR 114.24 million.	23/03/23	CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	07/02/23	CI
Jenburkt Pharmaceuticals Limited announces an Equity Buyback for INR 116 million worth of its shares.	01/12/22	CI
Jenburkt Pharmaceuticals Limited authorizes a Buyback Plan.	30/11/22	CI
Jenburkt Pharmaceuticals Board to Consider Share Buyback	29/11/22	MT
Jenburkt Pharmaceuticals Limited's Board intends to launch an Equity Buyback on December 1, 2022.	27/11/22	CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	08/11/22	CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	01/08/22	CI
Jenburkt Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022	30/07/22	CI
Ex-dividend day for final dividend	20/07/22	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Jenburkt Pharmaceuticals Limited

Equities

JENBURPH6

INE354A01013

Highlights

Filters